Screener/Healthcare/Drug Manufacturers - Specialty & Generic

SUPN

Supernus Pharmaceuticals, Inc.NASDAQ
$49.32+0.07 (+0.14%)
Mid CapUnder $50Healthcare
$29.16
$59.68
$48.23
$49.87
EPS (TTM)$-0.68
P/E Ratio—
Dividend Yield—
Market Cap$2.84B
Volume314K
Prev Close$49.25
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$211.6M-$4.1M$-0.0789.1%-1.9%
Q3 '25$192.1M-$45.1M$-0.8090.1%-23.5%
Q2 '25$165.5M$22.5M$0.4089.8%13.6%
Q1 '25$149.8M-$11.8M$-0.2189.5%-7.9%
Q4 '24$174.2M$15.3M$0.2785.0%8.8%
Q3 '24$175.7M$38.5M$0.6990.0%21.9%
Q2 '24$168.3M$19.9M$0.3689.4%11.8%
Q1 '24$143.6M$124K$0.0088.6%0.1%
Get Your Daily Market Recap